Atomi Financial Group’s Charles River Laboratories CRL Stock Holding History

Atomi Financial Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Sell	1,610 -58	-3%	-$10.8K	0.01%	995
2025 Q4	$333K	Buy	1,668 +273	+20%	+$49.5K	0.01%	884
2025 Q3	$218K	Buy	+1,395	New	+$222K	0.01%	1078
2025 Q2	–	Sell	-1,879	Closed	-$283K	–	1123
2025 Q1	$283K	Buy	1,879 +265	+16%	+$44.4K	0.01%	800
2024 Q4	$298K	Sell	1,614 -218	-12%	-$42K	0.02%	725
2024 Q3	$361K	Sell	1,832 -82	-4%	-$17K	0.02%	592
2024 Q2	$395K	Sell	1,914 -82	-4%	-$18.6K	0.03%	465
2024 Q1	$541K	Buy	+1,996	New	+$477K	0.05%	325

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atomi Financial Group's CRL Position: Q1 2026 in Review

Atomi Financial Group reduced its Charles River Laboratories (CRL) stake by 3.5% in Q1 2026, selling an estimated $10.8K and leaving 1,610 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #995.

Atomi Financial Group first reported a position in CRL in Q1 2024 and has held it in 8 quarters since. The position peaked at $541K in Q1 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Atomi Financial Group held 1,610 shares of Charles River Laboratories worth $278K as of Q1 2026.
Atomi Financial Group sold 58 Charles River Laboratories shares in Q1 2026, an estimated $10.8K.
Charles River Laboratories made up 0.01% of Atomi Financial Group's portfolio in Q1 2026, its #995 holding.
Atomi Financial Group first reported a position in Charles River Laboratories in Q1 2024 and has held it in 8 quarters since.
Atomi Financial Group's Charles River Laboratories position peaked at $541K in Q1 2024.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.